Mycitracin Plus Ointment 14 gm Indications
Mycitracin Plus Oint 14 gm is primarily indicated in conditions like Bacteremia, Meningitis, Superficial infections, Urinary tract infection, and can also be given in adjunctive therapy as an alternative drug of choice in Joint infections, Skin infections.
Mycitracin Plus Oint 14 gm is contraindicated in conditions like Hypersensitivity to the drug.
The severe or irreversible adverse effects of Mycitracin Plus Oint 14 gm, which give rise to further complications include Convulsions, Coma, Psychosis, Hypersensitivity reactions, Neuromuscular blockage.Mycitracin Plus Oint 14 gm produces potentially life-threatening effects which include Nephrotoxicity, Neurotoxicity, Hematuria, Respiratory paralysis. which are responsible for the discontinuation of Mycitracin Plus Oint 14 gm therapy. The symptomatic adverse reactions produced by Mycitracin Plus Oint 14 gm are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Drowsiness, Ataxia, Nausea, Vomiting, Blurred vision, Confusion, Urticaria, Flushing, Muscle weakness, Paresthesias, Proteinuria, Reaction at injection site, Azotemia.
Before initiating therapy with polymyxin B determine baseline kidney function. Serum concentration must be monitored regularly during treatment. It should be used with caution in patients with renal impairment, mysthania gravis or other condition of neuromuscular disease, in patients known to have hypersensitivity reactions, in pulmonary disease, if sign of respiratory distress or nephrotoxicity occur, the drug should be discontinued. Take appropriate measures in case of secondary infection.